SCHEMBL9897189

SCHEMBL9897189

Cc1cccc(C(C)(C(=O)Nc2nc3ccccc3o2)c2ccc(S(C)(=O)=O)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.40
PTGS2 P35354 1/20 0.40
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 2/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN5 P54829 1/20 0.39
MAPT P10636 3/20 0.39
ALOX15 P16050 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 1/20 0.38
CASP6 P55212 1/20 0.38
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
P2RY14 Q15391 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1464656 0.78 PTGS2 (0.49) SCDPTGS2NPC1RAB9ASMN1; SMN2
SCHEMBL9894832 0.71 CSNK1D (0.70) SCDPTGS2NPC1RAB9ASMN1; SMN2
SCHEMBL1463901 0.69 CNR2 (0.59) SCDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL9897188 0.68 PTPN2 (0.46) SCDPTGS2NPC1RAB9ASMN1; SMN2
SCHEMBL10005070 0.68 KDM4E (0.49) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL9897184 0.67 PTGS2 (0.44) SCDPTGS2NPC1RAB9ASMN1; SMN2
SCHEMBL13490131 0.66 MAPT (0.59) SCDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL30606758 0.66 XDH (0.45) SCDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL1465673 0.66 CNR2 (0.51) SCDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL9895215 0.66 NPC1 (0.44) SCDPTGS2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 SCD 3825/4885PTGS2 1485/4885NPC1 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.